A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples